Efficacy and safety of cagrilintide 2.4 mg in adults with overweight obesity: Data from REDEFINE 1 Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Good looking results for Novo Nordisk's combo of GLP1ra semaglutide (known as #ozempic for #diabetes & #wegovy for obesity) + Cagrilintide (amylin agonist) to achieve #weightloss in obesity and obesity with type Development of Cagrilintide, a Long Acting Amylin Analogue Journal of Medicinal Chemistry Chronic combination therapy of amylin and GLP 1R analogs results in Download Scientific Diagram